Latest update May 23rd, 2026 5:48 AM
Latest News
- TEN AK-47s SEIZED …Major firearms haul sparks high-stakes police probe in Berbice
- ‘Renegotiation of oil deal not anti-business’ – APNU
- Pres. Ali defends U.S. multi-million-dollar GTE deal with troubled contractor
- ‘Big Market’ vendors lament high cost-of-living, decline in business
- Iran says ‘deep and significant’ gaps with U.S. remain in talks to end war
Guyana looking to India to help meet its ‘safe medicines’ demands
“Only safe and effective medicines will be made available to Guyanese citizens.”
This was the assertion of public health officials as they engaged potential suppliers of pharmaceuticals to the local market.
The potential suppliers are from India and the move to embrace this level of collaboration is a direct result of Guyana and India’s mutual cooperation in health to ensure only pharmaceuticals, drugs and medicines deemed safe by Guyanese authorities will be sold here.
This was the focus of a discussion between key representatives of the two countries recently.
According to information released by the Public Health Ministry yesterday, on Tuesday Director of Pharmacy, Mr. Oneil Atkins, and Director of the Government Analyst Food and Drug Department [GA-FDD], Mr. Marlan Cole, took the opportunity to outline the country’s strict public health policies during a recent meeting.
The two-day meeting was held with representatives of the Indian Chambers of Commerce and the Pharmaceutical Export Promotion Board on the sidelines of the just-concluded Fourth International Conference on Pharmaceuticals and Medical Devices held in Bengaluru, India. According to Atkins, the two countries ha
Mr. Oneil Atkins and Mr. Marlan Cole [second and third from left] in the presence of Indian officials at the 4th International Conference on Pharmaceuticals and Medical Devices held in Bengaluru, India.
The Fourth International Conference on Pharmaceuticals and Medical Devices was held under the theme ‘Enabling Quality Affordable Healthcare’.
During the annual conference, Cole challenged the representatives to “do all in their power” to encourage manufacturers in India desiring a stake in the global drug market to ensure their products can withstand international scrutiny of reputable medicines reference authorities.
During the interview, Cole also outlined Guyana’s requirements for registration of medicines in the country. Even as Atkins alluded to the fact that the Indian manufacturers seek to assure quality export products will be made available, he strongly advocated that other manufacturers follow their example.
Participants from some 30 countries including Russia, Kenya, the United Kingdom [UK], Malaysia, Indonesia, Saudi Arabia and Uzbekistan, along with drug regulators from 15 Indian states attended the conference which was organised by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers and the Government of India in collaboration with the Federation of Indian Chambers of Commerce and Industry [FICCI].
Some of the issues discussed included development of separate medical devices and over-the-counter [OTC] drug regulations; early decision on implementation of trade margin rationalization and addressing the issue of Active Pharmaceutical Ingredients [APIs] price escalation imported from China; incentivising innovations in the pharmaceutical and medical devices sector, and greater transparency in the functioning of National Pharmaceutical Pricing Authority [NPPA].
Share this:
Discover more from Kaieteur News
Subscribe to get the latest posts sent to your email.